Regular Aspirin Use Linked to Lower Colon Cancer Rates 

Regular Aspirin Use Linked to Lower Colon Cancer Rates. Credit | iStock
Regular Aspirin Use Linked to Lower Colon Cancer Rates. Credit | iStock

United States: According to the latest study, it is found that weekly intake of aspirin might lessen the imminent risk of developing colorectal cancer, especially in those with unhealthy life routines. 

The study also found that more of the younger generation is increasingly coming in danger of having the risk of colorectal cancer because of their more harmful lifestyle choices. 

More about the news 

The study analyzed over 108,000 men and women, with an average age of 49, for over thirty years. The researchers noted their aspirin intake and also assigned them lifestyle scores based on their BMI, diet, physical activity, alcohol consumption, and cigarette use, as Forbes reported. 

Regular Aspirin Use Linked to Lower Colon Cancer Rates. Credit | Getty Images
Regular Aspirin Use Linked to Lower Colon Cancer Rates. Credit | Getty Images

The study results were published in the AMA Oncology on Thursday, 

The scientists found that those with regular aspirin intake, which were considered as two or more standard 325 mg pills or at least six low-dose 81 mg tablets per week, had a lower risk of developing colorectal cancer

More about the aspirin benefits – Study 

As per the study, the benefits of the study were more prominent in those with the most unhealthy lifestyles, more specifically in those who were in the habit of regular cigarette smoking and with higher BMIs. 

This group has a 3.4 percent probability of getting colorectal cancer if they are on irregular aspirin intake. In contrast, it has a 2.12 percent chance of cancer if with a regular aspirin intake. 

In comparison, the participants with the most unhealthy lifestyles had a rate of 1.5 in the case of regular aspirin intake, along with 1.6 percent for the non-regular aspirin group, according to Forbes. 

How does aspirin lower the colorectal cancer risk? 

Moreover, as previous evidence suggests, aspirin could reduce the production of pro-inflammatory proteins or prostaglandins, which promote cancer development. 

This is the main reason aspirin lowers colorectal cancer risk.